Skip to content Skip to footer

International Cannabis Weekly: 368

September 27, 2024

Highlights

Share this story
Highlights

HOME CULTIVATION PROPOSED AS PART OF NEW CZECH CANNABIS LAW

People over the age of 21 would be able to legally grow up to three plants at home for personal use, as well as having up to 50 grams of dried cannabis at home.

READ MORE  »

CANNABIS CLUB APPLICATIONS CONTINUE TO RISE IN GERMANY – BUT GROWTH SLOWS

READ MORE »

NEW HEMP BILL COULD SOLVE INTOXICATING CANNABINOID ISSUES IN THE U.S.

READ MORE »

Highlights

Share this story
Europe
  • Most Germans are consuming cannabis for health reasons – but many still turn to the illicit market.
  • Cannabis markets in Europe and the U.S. are like ‘chalk and cheese’, industry insiders say.
  • DanCann Pharma plans reverse stock split, Allied Corp exports GMP product to Switzerland, and more from SEED.
  • As proposed hemp flower ban advances, Italian agency says industry fears are overstated.
  • GROW and Integro Clinics expand medical cannabis access scheme to include all UK university students.
  • Leva Clinic merges with Zerenia to expand patient care and promote medical cannabis as a pain management solution.

Highlights

Share this story
Upcoming Event

Highlights

Share this story
United States

Highlights

Share this story
Canada
  • Canada’s cannabis sales rise for fifth consecutive month, but total 2024 sales continue to lag.
  • Canadian cannabis retail giant Tokyo Smoke restructures, seeking stronger future via CA$56.7 million share deal.
  • Tilray Brands has entered the US THC drinks market with a range of Delta-9 THC mocktails and seltzers.
  • Village Farms International buys remaining equity in Dutch cannabis producer Leli Holland.

Highlights

Share this story
LATAM & The Caribbean

Highlights

Share this story
APAC
  • Global hemp industry leaders attend Japan’s first International Hemp Conference in Tokyo.
  • More details emerge on Thailand’s new cannabis regulation bill, including the formation of a Cannabis Control Board.
  • ECS Botanics secures rights to roll out Terphogz range in Germany, Australia, and New Zealand.
  • Chinese study shows Epidiolex may have potential as a treatment for illness in veterans.

Highlights

Share this story
Africa & The Middle East
Latest Issues

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.

Market Briefing Request

Please complete your details and a representative will be in contact

In Depth Analysis Session Request

Please complete your details and a representative will be in contact

Data Access Request

Please complete your details and a representative will be in contact